Market revenue in 2023 | USD 2.5 million |
Market revenue in 2030 | USD 5.9 million |
Growth rate | 13% (CAGR from 2023 to 2030) |
Largest segment | Pure prp |
Fastest growing segment | Leukocyte Rich PRP |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pure PRP, Leukocyte Rich PRP |
Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Pure prp was the largest segment with a revenue share of 48% in 2023. Horizon Databook has segmented the Thailand platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
In Thailand, treating Achilles tendinitis, plantar fasciitis, chronic ankle pain, and similar conditions has become less challenging with the introduction of PRP injections. PRP has been demonstrated as an effective method for repairing injured areas in these conditions.
Typically, patients with plantar fasciitis, which is common among the elderly, receive initial treatments like physiotherapy, activity modification, weight management, and supportive devices like silicone insoles and appropriate footwear. However, if these initial approaches do not yield improvement, doctors may recommend PRP injections as an alternative treatment option, offering new opportunities for patients in Thailand.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account